Contact Us

HOTEL NEWS

A SPAC III Acquisition Corp. Announces Closing of $55 Million Initial Public Offering

Nov 13, 2024

HONG KONG,Nov. 13,2024-- A SPAC III Acquisition Corp. (the "Company"),a blank check company incorporated as a British Virgin Islands exempted company formed for the purpose of effecting a me

YCH Group Partners with Vietnamese Government to Propel SMEs onto the Global Stage

Nov 13, 2024

SINGAPORE,Nov. 13,2024-- In a significant move to strengthen Vietnam\'s presence in international markets,the country\'s Minister of Information and Communications,Nguyen Manh Hung,has invited Singap

Innodisk Introduces E1.S Edge Server SSD for the Future of Edge Computing and AI

Nov 13, 2024

TAIPEI,Nov. 13,2024-- Innodisk,a leading global AI solution provider,has introduced its new E1.S SSD,which is specifically designed to meet the demands of growing edge computing applications. The E1.

Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum's Disease Treatment

Nov 13, 2024

- CBL-514 is the first and only drug to receiveEMA Orphan Drug Designation for Dercum\'s disease treatment.

BLUETTI Unveils Elite 200 Portable Power Station Promising Over 17 Years of Dependable Charging

Nov 13, 2024

LAS VEGAS,Nov. 13,2024-- BLUETTI,a leader in portable power stations and eco-friendly energy solutions,launches the Elite 200 V2,a 2KWh all-powerful portable power station designed for easy and conve

A Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Included in the Pilot Program for Optimizing the Review and Approval of Clinical Trials for Innovative Drugs

Nov 13, 2024

SUZHOU,China,Nov. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that a clinical trial (Study ID: JSKN033-102) of JSKN033,a high-concentration subcutaneous co-formulation consisting of an

1 ... 233 234 235 236 237 238 239 ... 368